Paul Samuel

1.6k total citations
38 papers, 1.2k citations indexed

About

Paul Samuel is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Paul Samuel has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 11 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Paul Samuel's work include Lipoproteins and Cardiovascular Health (10 papers), Pharmacology and Obesity Treatment (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Paul Samuel is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Pharmacology and Obesity Treatment (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Paul Samuel collaborates with scholars based in United States, South Africa and Germany. Paul Samuel's co-authors include William Perl, Edward Meilman, Mark Z. Jacobson, Norman T. Ilowite, Ellen M. Ginzler, Anne C. Goldberg, John R. Guyton, John B. Rodgers, Richard Sachson and David M. Capuzzi and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

Paul Samuel

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Samuel United States 20 572 315 240 163 144 38 1.2k
W Jaroß Germany 19 648 1.1× 259 0.8× 293 1.2× 99 0.6× 89 0.6× 73 1.3k
B. Angelin Sweden 18 623 1.1× 290 0.9× 207 0.9× 81 0.5× 210 1.5× 36 1.1k
J. P. Blomhoff Norway 21 506 0.9× 246 0.8× 225 0.9× 65 0.4× 179 1.2× 53 1.2k
J.G. Brook Israel 23 787 1.4× 480 1.5× 247 1.0× 150 0.9× 50 0.3× 76 1.7k
Reagan H. Bradford United States 21 992 1.7× 457 1.5× 267 1.1× 98 0.6× 48 0.3× 43 1.7k
Tu T. Nguyen United States 18 733 1.3× 492 1.6× 207 0.9× 96 0.6× 76 0.5× 30 1.3k
B Angelin Sweden 22 943 1.6× 576 1.8× 407 1.7× 172 1.1× 347 2.4× 28 1.7k
James B. Moberly United States 20 432 0.8× 224 0.7× 287 1.2× 71 0.4× 76 0.5× 51 1.1k
G. Kakis Canada 15 380 0.7× 343 1.1× 183 0.8× 91 0.6× 270 1.9× 25 1.0k
G. R. Thompson United Kingdom 16 749 1.3× 451 1.4× 161 0.7× 122 0.7× 29 0.2× 29 1.3k

Countries citing papers authored by Paul Samuel

Since Specialization
Citations

This map shows the geographic impact of Paul Samuel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Samuel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Samuel more than expected).

Fields of papers citing papers by Paul Samuel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Samuel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Samuel. The network helps show where Paul Samuel may publish in the future.

Co-authorship network of co-authors of Paul Samuel

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Samuel. A scholar is included among the top collaborators of Paul Samuel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Samuel. Paul Samuel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kroner, John, Hua He, Paul Samuel, et al.. (2021). Longitudinal atopic dermatitis endotypes: An atopic march paradigm that includes Black children. Journal of Allergy and Clinical Immunology. 149(5). 1702–1710.e4. 34 indexed citations
2.
Goldberg, Anne C., Peter Alagona, David M. Capuzzi, et al.. (2000). Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia. The American Journal of Cardiology. 85(9). 1100–1105. 179 indexed citations
3.
Ilowite, Norman T., et al.. (1989). Dyslipoproteinemia in juvenile rheumatoid arthritis. The Journal of Pediatrics. 114(5). 823–826. 26 indexed citations
4.
Samuel, Paul, et al.. (1988). Effects of isradipine, a new calcium antagonist, versus hydrochlorothiazide on serum lipids and apolipoproteins in patients with systemic hypertension. The American Journal of Cardiology. 62(16). 1068–1071. 9 indexed citations
5.
Ilowite, Norman T., Paul Samuel, Ellen M. Ginzler, & Mark Z. Jacobson. (1988). Dyslipoproteinemia in pediatric systemic lupus erythematosus. Arthritis & Rheumatism. 31(7). 859–863. 110 indexed citations
6.
Knopp, Robert H., W. Virgil Brown, Carlos A. Dujovne, et al.. (1987). Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia. The American Journal of Medicine. 83(5). 50–59. 54 indexed citations
7.
Samuel, Paul, et al.. (1986). Improvement of the lipid profile during long-term administration of pindolol and hydrochlorothiazide in patients with hypertension. The American Journal of Cardiology. 57(5). C24–C28. 8 indexed citations
8.
Samuel, Paul. (1983). Effects of Gemfibrozil on Serum Lipids. The American Journal of Medicine. 74(5). 23–27. 22 indexed citations
9.
Samuel, Paul. (1979). Treatment of Hypercholesterolemia with Neomycin — A Time for Reappraisal. New England Journal of Medicine. 301(11). 595–597. 27 indexed citations
10.
Samuel, Paul, et al.. (1978). The relationship between serum cholesterol and fecal 7α-dehydroxylase activity in three ethnic groups in South Africa. Atherosclerosis. 31(2). 177–184. 3 indexed citations
11.
Watson, John B., et al.. (1975). Fat, calcium and nitrogen balance in full-term infants.. PubMed. 51 suppl 3. 45–51. 2 indexed citations
12.
Deutsch, Stanley, et al.. (1974). Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia. American Journal of Clinical Nutrition. 27(1). 22–28. 15 indexed citations
13.
Samuel, Paul, et al.. (1974). Relation of serum cholesterol to in vitro 7alpha-dehydroxylation of primary bile acids by fecal bacteria in infants and children.. PubMed. 54(2). 222–8. 7 indexed citations
14.
Samuel, Paul, et al.. (1973). Improved estimation of body masses and turnover of cholesterol by computerized input–output analysis. Journal of Lipid Research. 14(2). 189–196. 56 indexed citations
15.
Samuel, Paul, et al.. (1970). Variation of Total Serum Cholesterol Concentration in Patients with Atherosclerosis. American Journal of Clinical Nutrition. 23(2). 178–188. 8 indexed citations
16.
Perl, William & Paul Samuel. (1969). Input-Output Analysis for Total Input Rate and Total Traced Mass of Body Cholesterol in Man. Circulation Research. 25(2). 191–199. 65 indexed citations
17.
Samuel, Paul, et al.. (1965). Effect of Yoghurt on Serum Cholesterol. Journal of the American Dietetic Association. 47(3). 192–193. 4 indexed citations
18.
Samuel, Paul, Morton Urivetzky, & Gabor Kaley. (1964). Separation and radioassay of fecal cholesterol and coprosterol using thin-layer chromatography. Journal of Chromatography A. 14. 508–509. 7 indexed citations
19.
Samuel, Paul, et al.. (1964). Effect of Vitamin C on Serum Cholesterol in Patients with Hypercholesterolemia and Arteriosclerosis. Circulation. 29(1). 24–25. 21 indexed citations
20.
Samuel, Paul, et al.. (1961). Reduction of Serum Cholesterol Concentrations by Neomycin, Para-aminosalicylic Acid, and Other Antibacterial Drugs in Man. Circulation. 24(3). 578–591. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W Jaroß Breakdown of academic impact, for papers by B. Angelin Breakdown of academic impact, for papers by J. P. Blomhoff Breakdown of academic impact, for papers by J.G. Brook Breakdown of academic impact, for papers by Reagan H. Bradford Breakdown of academic impact, for papers by Tu T. Nguyen Breakdown of academic impact, for papers by B Angelin Breakdown of academic impact, for papers by James B. Moberly Breakdown of academic impact, for papers by G. Kakis Breakdown of academic impact, for papers by G. R. Thompson
Rankless by CCL
2026